LOW-DOSE ORAL CHEMOTHERAPY FOR HORMONE REFRACTORY PROSTATE CARCINOMA (HRPC)

[scarica PDF]
LOW-DOSE ORAL CHEMOTHERAPY FOR HORMONE REFRACTORY PROSTATE CARCINOMA (HRPC). ESTRAMUSTINE PHOSPHATE VERSUS ESTRAMUSTINE PHOSPHATE AND ETOPOSIDE. A RANDOMISED PHASE II STUDY OF G.S.T.U. FOUNDATION
V Serretta1, G Morgia2, V Altieri3, A Siragusa4, M Motta5, F Orestano6, M Napoli7, G De Grande8, A Galuffo1, D Melloni1, C Pavone1, M Pavone Macaluso1, R Allegro1, all members of G.S.T.U.9
1University Of Palermo, Urology, Palermo, Italy, 2University Of Sassari, Urology, Sassari, Italy, 3University Of Napoli, Urology, Napoli, Italy, 4Civic Hospital, Urology, Caltagirone (CT), Italy, 5University Of Catania, Urology, Catania, Italy, 6Private Clinic, Urology, Palermo, Italy, 7Civic Hospital, Urology, Trapani, Italy, 8Civic Hospital, Urology, Siracusa, Italy, 9G S T U, Foundation, Sicilia, Calabria, Campania, Molise, Puglia, Basilicata, Italy

l1